Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Houben, RMGJ"'
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 25:1001-1005
BACKGROUND: Tests that identify individuals at greatest risk of TB will allow more efficient targeting of preventive therapy. The WHO target product profile for such tests defines optimal sensitivity of 90% and minimum sensitivity of 75% for predicti
Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia
Autor:
Parwati, CG, Farid, MN, Nasution, HS, Basri, C, Lolong, D, Gebhard, A, Tiemersma, EW, Pambudi, I, Surya, A, Houben, RMGJ
SETTING: In many high tuberculosis (TB) burden countries, there is substantial geographical heterogeneity in TB burden. In addition, decisions on TB funding and policy are highly decentralised. Subnational estimates of burden, however, are usually un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::2df5fbac6bb23f572cec7cce1a7727f9
https://researchonline.lshtm.ac.uk/id/eprint/4656725/1/R1_Manuscript_IJTLD_20190515.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4656725/1/R1_Manuscript_IJTLD_20190515.pdf
Autor:
White, RG, Charalambous, S, Cardenas, V, Hippner, P, Sumner, T, Bozzani, F, Mudzengi, D, Houben, RMGJ, Collier, D, Kimerling, ME, Vassall, A, Pillay, Y, Churchyard, G
BACKGROUND: National Tuberculosis Programmes (NTPs) require specialist input to support the development of policy and practice informed by evidence, typically against tight deadlines. OBJECTIVE: To describe lessons learned from establishing a dedicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::6662e1a5b4de3c32d2ddce2452ba4dad
Autor:
Verguet, S, Riumallo Herl, Carlos, Gomez, GB, Menzies, NA, Houben, RMGJ, Summer, T, Lalli, M, White, RG, Salomon, J, Cohen, T, Foster, N, Chatterjee, S, Sweeney, S, Baena, IG, Lönnroth, K, Weil, D, Vassall, A
Publikováno v:
The Lancet Global Health, 5(11), 1123-1132. Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::2a0354730563afc760d60f706c996336
https://pure.eur.nl/en/publications/77f316cd-55f4-477b-87f2-66690ee46b81
https://pure.eur.nl/en/publications/77f316cd-55f4-477b-87f2-66690ee46b81
Autor:
Houben, RMGJ, Dowdy, DW, Vassall, A, Cohen, T, Nicol, MP, Granich, RM, Shea, JE, Eckhoff, P, Dye, C, Kimerling, ME, White, RG, TB MAC TB-HIV meeting participants
Existing approaches to tuberculosis (TB) control have been no more than partially successful in areas with high human immunodeficiency virus (HIV) prevalence. In the context of increasingly constrained resources, mathematical modelling can augment un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ea3a14fd434fafbb7fce4f3f12355f26
https://researchonline.lshtm.ac.uk/id/eprint/1776689/1/i1027-3719-18-5-509.pdf
https://researchonline.lshtm.ac.uk/id/eprint/1776689/1/i1027-3719-18-5-509.pdf
Publikováno v:
American Journal of Epidemiology
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Horton, KC
Background: Tuberculosis (TB) case notifications among men outnumber those among women, yet sex disparities in TB burden and access to care are not well-understood. Methods: Systematic reviews, meta-analyses, and mathematical modelling were utilised
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc910e777256939c6ff48f173a90f3ba
Autor:
Schwalb A; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru. Electronic address: alvaro.schwalb@lshtm.ac.uk., Goscé L; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; Institute for Global Health, University College London, London, UK., Houben RMGJ; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Publikováno v:
The Lancet. Public health [Lancet Public Health] 2024 Oct 14. Date of Electronic Publication: 2024 Oct 14.
Autor:
Churchyard GJ; Aurum Institute NPC, Houghton, Parktown, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA; School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. Electronic address: gchurchyard@auruminstitute.org., Houben RMGJ; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Fielding K; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Fiore-Gartland AL; University of Washington, Seattle, WA, USA., Esmail H; MRC Clinical Trials Unit, University College London, London, UK; WHO Collaborating Centre for TB Research and Innovation, Institute for Global Health, University College London, London, UK., Grant AD; TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Rangaka MX; MRC Clinical Trials Unit, University College London, London, UK; CIDRI-AFRICA, School of Public Health, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Behr M; McGill International TB Centre, McGill University, Montreal, QC, Canada., Garcia-Basteiro AL; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain., Wong EB; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa; Division of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Hatherill M; South African Tuberculosis Vaccine Initiative, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Mave V; Byramjee-Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, India., Dagnew AF; Gates Medical Research Institute, Cambridge, MA, USA., Schmidt AC; Gates Medical Research Institute, Cambridge, MA, USA., Hanekom WA; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Cobelens F; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., White RG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Publikováno v:
The Lancet. Microbe [Lancet Microbe] 2024 Oct; Vol. 5 (10), pp. 100895. Date of Electronic Publication: 2024 Jul 01.